These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17712257)

  • 21. HEMOGLOBIN A1C, BLOOD PRESSURE, AND LDL-CHOLESTEROL CONTROL AMONG HISPANIC/LATINO ADULTS WITH DIABETES: RESULTS FROM THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL).
    Casagrande SS; Aviles-Santa L; Corsino L; Daviglus ML; Gallo LC; Espinoza Giacinto RA; Llabre MM; Reina SA; Savage PJ; Schneiderman N; Talavera GA; Cowie CC
    Endocr Pract; 2017 Oct; 23(10):1232-1253. PubMed ID: 28816530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S; Ghanaat F; Tayek JA
    Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes.
    Kirk JK; Bell RA; Bertoni AG; Arcury TA; Quandt SA; Goff DC; Narayan KM
    Ann Pharmacother; 2005 Sep; 39(9):1489-501. PubMed ID: 16076917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002.
    Saaddine JB; Cadwell B; Gregg EW; Engelgau MM; Vinicor F; Imperatore G; Narayan KM
    Ann Intern Med; 2006 Apr; 144(7):465-74. PubMed ID: 16585660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does quality of care for cardiovascular disease and diabetes differ by gender for enrollees in managed care plans?
    Bird CE; Fremont AM; Bierman AS; Wickstrom S; Shah M; Rector T; Horstman T; Escarce JJ
    Womens Health Issues; 2007; 17(3):131-8. PubMed ID: 17434752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change.
    Grant RW; Buse JB; Meigs JB;
    Diabetes Care; 2005 Feb; 28(2):337-442. PubMed ID: 15677789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multistrategic approach to improve quality of care of people with diabetes at the primary care level: Study design and baseline data.
    Prestes M; Gayarre MA; Elgart JF; Gonzalez L; Rucci E; Gagliardino JJ;
    Prim Care Diabetes; 2017 Apr; 11(2):193-200. PubMed ID: 28065677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Pay-for-Performance Incentive Designs on Diabetes Care.
    Hsieh HM; Shin SJ; Tsai SL; Chiu HC
    Med Care; 2016 Dec; 54(12):1063-1069. PubMed ID: 27479599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study.
    Cai X; Hu D; Pan C; Li G; Lu J; Ji Q; Su B; Tian H; Qu S; Weng J; Zhang D; Xu J; Ji L
    Sci Rep; 2019 May; 9(1):7709. PubMed ID: 31118445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home.
    Joseph J; Koka M; Aronow WS
    J Am Med Dir Assoc; 2008 Jan; 9(1):51-4. PubMed ID: 18187113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Welltang - A smart phone-based diabetes management application - Improves blood glucose control in Chinese people with diabetes.
    Zhou W; Chen M; Yuan J; Sun Y
    Diabetes Res Clin Pract; 2016 Jun; 116():105-10. PubMed ID: 27321324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
    Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
    Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does good clinical practice at the primary care improve the outcome care for diabetic patients? Gender differences.
    Bener A; Abdulmalik M; Al-Kazaz M; Sanya R; Buhmaid S; Al-Harthy M; Mohammad AG
    Prim Care Diabetes; 2012 Dec; 6(4):285-92. PubMed ID: 22622594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a chronic care coordinator intervention on diabetes quality of care in a community health center.
    Solorio R; Bansal A; Comstock B; Ulatowski K; Barker S
    Health Serv Res; 2015 Jun; 50(3):730-49. PubMed ID: 25355532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins.
    Hasegawa Y; Hori M; Nakagami T; Harada-Shiba M; Uchigata Y
    J Clin Lipidol; 2018; 12(1):62-69.e1. PubMed ID: 29217412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems.
    Schroeder EB; Hanratty R; Beaty BL; Bayliss EA; Havranek EP; Steiner JF
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):645-53. PubMed ID: 22851534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control.
    Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Duh MS; Lefebvre P
    J Med Econ; 2015 Feb; 18(2):113-25. PubMed ID: 25350645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].
    Voorham J; Haaijer-Ruskamp FM; van der Meer K; de Zeeuw D; Wolffenbuttel BH; Hoogenberg K; Denig P
    Ned Tijdschr Geneeskd; 2010; 154():A775. PubMed ID: 20132579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.